Genetic epidemiology of dengue viruses in phae III trials of the CYD tetravalent dengue vaccine and implications for efficacy
| dc.date.accessioned | 2018-09-14T11:15:03Z | |
| dc.date.available | 2017-10-11T01:12:07Z | |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2017-08-03 | en_US |
| dc.date.available | 2018-09-14T11:15:03Z | |
| dc.date.issued | 2017-09-05 | en_US |
| dc.description.abstract | This study defined the genetic epidemiology of dengue viruses (DENV) in two pivotal phase III trials of the tetravalent dengue vaccine, CYD-TDV, and thereby enabled virus genotype-specific estimates of vaccine efficacy (VE). Envelope gene sequences (n = 661) from 11 DENV genotypes in 10 endemic countries provided a contemporaneous global snapshot of DENV population genetics and revealed high amino acid identity between the E genes of vaccine strains and wild-type viruses from trial participants, including at epitope sites targeted by virus neutralising human monoclonal antibodies. Post-hoc analysis of all CYD14/15 trial participants revealed a statistically significant genotype-level VE association within DENV-4, where efficacy was lowest against genotype I. In subgroup analysis of trial participants age 9-16 years, VE estimates appeared more balanced within each serotype, suggesting that genotype-level heterogeneity may be limited in older children. Post-licensure surveillance is needed to monitor vaccine performance against the backdrop of DENV sequence diversity and evolution. | |
| dc.identifier.uri | http://localhost:8080/dspace7/handle/123456789/180 | |
| dc.language | English | en_US |
| dc.title | Genetic epidemiology of dengue viruses in phae III trials of the CYD tetravalent dengue vaccine and implications for efficacy | en_US |
| dc.type | Journal Article |